PETHEMA (Program for the Study and Treatment of Haematological Malignances)赞助的临床试验
总计2个结果
-
Wyeth is now a wholly owned subsidiary of PfizerPETHEMA (Program for the Study and Treatment of Haematological Malignances)完全的
-
PENTA FoundationKarolinska Institutet; Centre Hospitalier Universitaire Saint Pierre; Centro Hospitalar do Porto; MRC Clinical Trials Unit at UCL 和其他合作者主动，不招人艾滋病毒感染 | 新冠肺炎 | 丙型肝炎 | 结核感染